{"id":339719,"date":"2026-11-04T21:22:21","date_gmt":"2026-11-04T15:52:21","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/novartis-india-q2-results-fy27-loss-78-crore\/"},"modified":"2026-11-04T21:22:21","modified_gmt":"2026-11-04T15:52:21","slug":"novartis-india-q2-results-fy27-loss-78-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/novartis-india-q2-results-fy27-loss-78-crore\/","title":{"rendered":"Novartis India Q2 Results FY27: Net Loss Rs 77.54 Cr, Revenue Rs 56.05 Cr Down 37.95%"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Novartis India Q2 Results FY27 were declared on 3 November 2026. Revenue stood at Rs 56.05 Cr, down 37.95% YoY from Rs 90.33 Cr, while net profit moved to a net loss of Rs 77.54 Cr from a profit of Rs 24.22 Cr a year earlier, a 420.15% YoY decline. These quarterly results show the YoY growth direction for both lines, with net profit margin at -138.3% against 26.8% in the comparison quarter.<\/p>\n<\/div>\n

Novartis India Ltd (NOVARTIND) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought revenue of Rs 56.05 Cr and a net loss of Rs 77.54 Cr into view, and Novartis India Q2 Results FY27 show revenue down 37.95% and net profit down 420.15% against a year earlier.<\/p>\n

This results analysis of Novartis India Q2 Results covers the financial highlights, business drivers, outlook and risks behind the numbers. It begins with the Financial Highlights table, which sets this quarter against the same quarter last year.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n